HBV相关肾小球肾炎的研究进展

安爽; 张睿; 杨文轩; 周鸿捷; 张泽天; 杨以良; 郭晓林

doi:10.3969/j.issn.1001-5256.2016.02.037

HBV相关肾小球肾炎的研究进展

DOI: 10.3969/j.issn.1001-5256.2016.02.037

吉林大学第一医院肝胆胰内科

详细信息

中图分类号: R512.62;R692.31
计量
- 文章访问数: 1474
- HTML全文浏览量: 30
- PDF下载量: 462
- 被引次数: 0
出版历程
- 收稿日期: 2015-07-29
- 出版日期: 2016-02-20

Research advances in hepatitis B virus-associated glomerulonephritis

Department of Hepatology,The First Hospital of Jilin University

摘要

摘要: HBV相关肾小球肾炎（HBV-GN）是慢性HBV感染最常见的肝外损伤之一,近年来受到众多学者重视。阐述了HBV-GN相关危险因素、发病机制、病理特点及治疗等方面取得的进展。目前HBV-GN诊断率低、样本量少,认为该病具有较大的研究空间,未来需要更多、更优质的临床试验去探索解决方案。
- 肝炎病毒,乙型 /
- 肾小球肾炎 /
- 治疗 /
- 综述
Abstract: Hepatitis B virus- associated glomerulonephritis( HBV- GN) is the most common extrahepatic injury induced by chronic hepatitis B virus( HBV) infection,which has been taken seriously by scholars in recent years. This article summarizes the research advances in related risk factors for HBV- GN,pathogenesis,and treatment. Since the diagnostic rate of HBV- GN is low and the sample size is small at present,there is still much space for research in this field. More clinical trials with good quality are needed in the future to investigate the therapeutic regimens for this disease.
- hepatitis B virus /
- glomerulonephritis /
- therapy /
- review

HTML全文

参考文献(33)

[1]COMBES B,SHOREY J,BARRERA A,et al.Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane[J].Lancet,1971,2(7718):234-237.

[2] Editorial Board of Chinese Journal of Internal Medicine.Minutes of the symposium on hepatitis B virus-associated glomerulonephritis[J].Chin J Intern Med,1990,29(9):519-521.(in Chinese)中华内科杂志编委会.乙型肝炎病毒相关性肾炎座谈会纪要[J].中华内科杂志,1990,29(9):519-521.

[3] BHIMMA R,COOVADIA HM.Hepatitis B virus-associated nephropathy[J].Am J Nephrol,2004,24(2):198-211.

[4]SHIMIZU I,KOHNO N,TAMAKI K,et al.Female hepatology:favorable role of estrogen in chronic liver disease with hepatitis B virus infection[J].World J Gastroenterol,2007,13(32):4295-4305.

[5]GILBERT RD,WIGGELINKHUIZEN J.The clinical course of hepatitis B virus-associated nephropathy[J].Pediatr Nephrol,1994,8(1):11-14.

[6]LAI KN,LAI FM,TAM JS.Comparison of poly-clonal and monoclonal antibodies in determi-nation of glomerular deposits of hepatitis B virus antigens in hepatitis B virus-associated glomerulonephritis[J].Am J Clin Pathol,1989,92(2):159-165.

[7]LIN CY,LIN CC,CHANG GJ,et al.Defect of cell-mediated immune response against hepatitis B virus:an indication of pathogenesis of hepatitis B virus-associated membranous nephropathy[J].Nephron,1997,76(2):176-185.

[8]HE XY,FANG LJ,ZHANG YE,et al.In situ hybridisation of hepatitis B DNA in hepatitis B-associated glomerulonephritis[J].Pediatr Nephrol,1998,12(2):117-120.

[9]LAI KN,LAI FM.Clinical features and the natural course of hepatitis B virus-related glomerulopathy in adults[J].Kidney Int Suppl,1991,35:s40-s45.

[10]TAKEKOSHI Y,TOCHIMARU H,NAGATA Y,et al.Immunopathogenetic mechanisms of hepatitis B virus-related glomerulopathy[J].Kidney Int Suppl,1991,35:s34-s49.

[11]LAI KN,LI PK,LUI SF,et al.Membranous nephropathy related to hepatitis B virus in adults[J].N Engl J Med,1991,324(21):1457-1463.

[12]BHIMMA R,COOVADIA HM.Hepatitis B virus-associated nephropathy[J].Am J Nephrol,2004,24(2):198-211.

[13]LU P,YU YH,ZHUANG YZ,et al.Clinicopathological analysis of hepatitis B virus-associated glomerulonephritis[J].Chin J Integr Tradit West Nephrol,2011,12(6):541-543.(in Chinese)卢萍,余英豪,庄永泽,等.乙型肝炎病毒相关性肾炎临床病理分析[J].中国中西医结合肾病杂志,2011,12(6):541-543.

[14]WANG NS.Research advances in hepatitis B virus-associated glomerulonephritis[C]∥Compilation of plenary lectures at The Fourth International Nephrology Conference of Integrated Traditional Chinese and Western Medicine.Tianjin:Nephrology Committee,China Society of Integrated Traditional Chinese and Western Medicine,2006:94-100.(in Chinese)汪年松.乙型肝炎病毒相关性肾炎的研究进展[C]∥第四届国际中西医结合肾脏病学术会议专题讲座汇编.天津:中国中西医结合学会肾病专业委员会,2006:94-100.

[15]LEI QY,ZHAO JH,TANG JY.Effects of hemodialysis on immune function of patients with end-stage nephropathy associated HBV virus infection[J].Chin J Immunol,2014,30(12):1679-1682.(in Chinese)雷湫宇,赵景宏,唐建英.血液透析对终末期肾病合并HBV病毒感染患者免疫功能的影响[J].中国免疫学杂志,2014,30(12):1679-1682.

[16]LIN CY.Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon[J].Kidney Int,1995,47(1):225-230.

[17]BHIMMA R,COOVADIA HM,KRAMVIS A,et al.Treatment of hepatitis B virus-associated nephropathy in blank children[J].Pediatr Nephrol,2002,17(6):393-399.

[18]CONJEEVARAM HS,HOOFNAGLE JH,AUSTIN HA,et al.Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa[J].Gastroenterology,1995,109(2):540-546.

[19]CHUNG DR,YANG WS,KIM SB,et al.Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon[J].Am J Nephrol,1997,17(2):112-117.

[20]KHEDMAT H,TAHERI S.Hepatitis B virus-associated nephropathy:an international data analysis[J].Iran J Kidney Dis,2010,4(2):101-105.

[21]YI Z,JIE YW,NAN Z.The efficacy of anti-viral therapy on hepatitis B virus-associated glomerulonephritis:a systematic review and meta-analysis[J].Ann Hepatol,2011,10(2):165-173.

[22] ZHENG XY,WEI RB,TANG L,et al.Meta-analysis of combined therapy for adult hepatitis B virus-associated glo-merulonephritis[J].World J Gastroenterol,2012,18(8):821-832.

[23]YANG YF,XIONG QF,ZHAO W,et al.Complete remission of hepatitis B virus-related membranous nephropathy after entecavir monotherapy[J].Clin Res Hepatol Gastroenterol,2012,36(5):e89-e92.

[24]DAS P,VIVEK V,FORD M,et al.Hepatitis B virus related membranous glomerulonephritis and proteinuria treated with lamivudine and tenofovir[J].BMJ Case Rep,2011,2011.pii:bcr0520114287.

[25]LAI KN,TAM JS,LIN HJ,et al.The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia[J].Nephron,1990,54(1):12-17.

[26]SAYARLIOGLU H,ERKOC R,DOGAN E,et al.Mycophenolate mofetil use in hepatitis B associated-membranous and membranoproliferative glomerulonephritis induces viral replication[J].Ann Pharmacother,2005,39(3):573.

[27]SHIN SK,RYU DR,HWANG JH,et al.Comparison between lamivudine alone and lamivudine and steroid combination in treatment of nephrotic syndrome associated with hepatitis B[J].Korean J Nephrol,1999,18(4):550-559.

[28]ZHENG XY,WEI RB,TANG L,et al.Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis[J].World J Gastroenterol,2012,18(8):821-832.

[29]MITKA M.FDA:Increased HBV reactivation risk with ofatumumab or rituximab[J].JAMA,2013,310(16):1664.

[30]GUILLEVIN L,MAHR A,CALLARD P,et al.Hepatitis B virus-associated polyarteritis nodosa:clinical characteristics,outcome,and impact of treatment in 115 patients[J].Medicine(Baltimore),2005,84(5):313-322.

[31]LUO D.Treatment of HBV-GN with mycophenolate combined with lamivudine:report of 30 cases[J].J Navy Medicine,2009,30(2):114-116.(in Chinese)骆丹.霉酚酸酯联合拉米呋啶治疗乙肝病毒相关性肾炎30例临床分析[J].海军医学杂志,2009,30(2):114-116.

[32]XIANG H,SUN J.Comparison between lenfluomide and mycophenolate mofeil treatment in HBV-associated glomerulonephritis[J].Clin Med Eng,2011,18(2):213-215.(in Chinese)向慧,孙剑.来氟米特与霉酚酸酯治疗乙肝病毒相关性肾炎的疗效比较[J].临床医学工程,2011,18(2):213-215.

[33]CHEN JL.Treatment in Hepatitis B virus-associated nephritis[J].J Continuing Med Education,2006,20(7):33-36.(in Chinese)陈京龙.乙型肝炎病毒相关性肾炎的治疗[J].继续医学教育,2006,20(7):33-36.

施引文献

资源附件(0)

访问统计